Vivek Rangnekar
Calculated based on number of publications stored in Pure and citations from Scopus
1985 …2022

Research activity per year

If you made any changes in Pure these will be visible here soon.
Filter
Chapter

Search results

  • 2017

    The effects of withaferin a on normal and malignant immune cells

    Alhakeem, S. S., McKenna, M. K., Oben, K. Z., Gachuki, B. W., Noothi, S. K., Muthusamy, N., Rangnekar, V. M., Gupta, R. C. & Bondada, S., Sep 13 2017, Science of Ashwagandha: Preventive and Therapeutic Potentials. p. 227-242 16 p.

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

  • 2014

    Cancer-selective apoptosis by tumor suppressor Par-4

    Hebbar, N., Shrestha-Bhattarai, T. & Rangnekar, V. M., 2014, Anticancer Genes. p. 155-166 12 p. (Advances in Experimental Medicine and Biology; vol. 818).

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    10 Scopus citations
  • 2013

    Role of Par-4 in prostate cancer

    Shukla, N., Hebbar, N. K. & Rangnekar, V. M., Jan 1 2013, Prostate Cancer: Biochemistry, Molecular Biology and Genetics. p. 481-495 15 p.

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    Open Access
    1 Scopus citations
Your message has successfully been sent.
Your message was not sent due to an error.